DNA Encoded Library market Size, Share, Trends by 2035

by kylie morgan in Accuracy in Media

In recent years, there has been a growth in the use of DNA encoded libraries, driven by several technological advancements and the growing demand for effective techniques for screening of potential drug targets



Roots Analysis has announced the addition of “DNA Encoded Library Market, 2023-2035” report to its list of offerings.


The report features an extensive study on the current landscape and the likely future potential of DNA encoded library market over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:

  • A detailed assessment of the overall landscape of DNA encoded library service providers / platform providers / in-house companies.
  • A detailed analysis of various business models adopted by the companies providing DNA encoded library platforms and services.
  • A detailed competitiveness analysis of DNA encoded libraries platform and service providers.
  • Elaborate profiles of the prominent platform and service providers (shortlisted based on a proprietary criterion) engaged in this market.
  • A detailed analysis of the partnerships inked between industry / non-industry stakeholders engaged in this industry, since 2010.
  • An analysis of funding and investments that have been made into companies having proprietary DNA encoded chemical library.
  • An in-depth analysis of various patents that have been filed / granted related to DNA encoded chemical library, since 2005.
  • A detailed analysis of various DNA encoded libraries focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2022).
  • A case study on companies / organizations that are presently engaged in supporting the development of DNA encoded libraries.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)


  • Application Area
    • Hit Generation / Identification
    • Hit to Lead
    • Hit Validation / Optimization
    • Other Application Areas


  • Therapeutic Area
  • Oncological Disorders
  • Immunological Disorders
  • Neurological Disorders
  • Respiratory Disorders
  • Dermatological Disorders
  • Cardiovascular Disorders
  • Infectious Diseases
  • Other Therapeutic Areas


  • End-user 
  • Pharma / Biopharma Industry
  • Academic / Research Institute
  • Other End-users


  • Type of Payment Model Employed
  • Upfront Payment
  • Milestone Payment
  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific


Key companies covered in the report

  • AlphaMa
  • DICE Therapeutics
  • DyNAbind
  • HitGen
  • NovAliX
  • Vipergen
  • WuXi AppTec
  • X-Chem


To view more details on this report, click on the link:



Learn from experts:  do you know about these emerging industry trends?

Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic?

Exploring How Artificial Intelligence Is Transforming Digital Pathology


About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.


Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting - the preferred research partner for global firms



Ben Johnson

+1 (415) 800 3415

[email protected]